Table 3.
LRF | LRC, G 0–2 | LRC, G 3–4 | |
n | 21 | 77 | 14* |
GTV PT (cc) | 63 | 32 | 31.4 |
GTV LN (cc) | 8.5 | 15 | 13 |
PTV1 (cc) | 174 | 154 | 176 |
% PTV1 >110 % | 0.8 | 0.8 | 1.3 |
% PTV1 < 95 % | 13.5 | 8.3 | 8.0 |
Gross tumor volume (GTV) in LRF patients was significantly larger than in controlled LRC individuals (p < 0.01). Isodose comparison showed PTV1 in controlled patients tendentially better covered, with less volumes getting doses < 95 %, compared with failed patients.
* : the 2 patients with xerostomia grade 3 and the 3 patients with ulcers related to tumor persistence were excluded from this analysis.